Shots: The US FDA has accepted the PR for NDA of mirabegron (oral suspension) and sNDA for Myrbetriq (mirabegron, tablets) for neurogenic detrusor overactivity (NDO) in pediatric patients aged ≥ […]readmore
Tags : Tablets
Shots: Zydus’s doxycycline hyclate delayed-release tablets has received FDA approval for 75 mg, 100 mg and 150 mg to treat or prevent infections to susceptible bacteria Zydus has also received […]readmore